Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profile.
Sturek JM, Thomas TA, Gorham JD, Sheppard CA, Raymond AE, Guex KP, Harrington WB, Barros AJ, Madden GR, Alkabab YM, Lu D, Liu Q, Poulter MD, Mathers AJ, Thakur A, Kubicka EM, Lum LG, Heysell SK.
Sturek JM, et al. Among authors: heysell sk.
medRxiv [Preprint]. 2021 Feb 19:2021.02.16.21251849. doi: 10.1101/2021.02.16.21251849.
medRxiv. 2021.
PMID: 33619508
Free PMC article.
Updated.
Preprint.